Page 23 - Hans Vitzthum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesSarah kielyHans vitzthumRobert stanislaroGerard platenburgExchange commissionEditing technologies for precision medicinesPeptide therapeuticsEditing technologiesPrecision medicinesChief innovation officerOligonucleotide discoveryAdenosine deaminase actingGlobe newswire

2022-05-09 | NDAQ:ALBO | Press Release | Albireo Pharma Inc

(2022-05-09 | NDAQ:ALBO) Albireo to Report Q1 2022 Financial Results on May 16

United statesVastra gotalands lanColleen alabisoLance buckleyHans vitzthumNational institute for healthAlbireo pharma incLifesci advisorsNational health serviceAlbireo closecurlyquoteOpen label extensionNational instituteCare excellenceNorthern ireland unitedHealthcare 37Biotechnology 121

Aerie Pharmaceuticals (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript

Aerie Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AERI) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Hans Vitzthum – LifeSci Partners Raj Kannan – Chief Executive.

United statesSerge belangerOren livnatRaj kannanStacy kuGary sternbergJeff calabreseHans vitzthumCasey kopczynskiJason gerberryBausch lombLouise chenAnnabel samimyPeter langCarly kenselaarYigal nochomovitz

Aerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

First Quarter Glaucoma Franchise Net Revenues of $29.8 Million, up 30% over First Quarter 2021Management Reaffirms 2022 Glaucoma Franchise Guidance of $130 Million to $140 MillionFirst Phase 3 Registrational Trial for AR-15512 On-Track for Enrollment Second Quarter of 2022DURHAM, N.C. (BUSINESS WIRE) Aerie Pharmac.

United statesAvizorex pharmaPeter langRaj kannanGary sternbergHans vitzthumCarolyn mcauliffeAerie pharmaceuticals incDrug administrationRegulatory agencyExchange commissionEuropean medicines agencyAerie pharmaceuticalsFirst quarter glaucoma franchise net revenuesFirst quarterFranchise guidance

Paratek Pharmaceuticals Announces First Quarter 2022 Revenue of $24 9 Million

Paratek Pharmaceuticals Announces First Quarter 2022 Revenue of $24 9 Million
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesChristine fanelleEvan lohHans vitzthumRare disease development programUs department of healthZai labParatek pharmaceuticals incDevelopment authorityExchange commissionBioshield anthrax programHuman service biomedical advanced researchCore commercial businessFirst quarterHollow fiberParatek pharmaceuticals